Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Other Accumulated Expenses (2020 - 2024)

RAPT Therapeutics' Other Accumulated Expenses history spans 5 years, with the latest figure at $61000.0 for Q3 2024.

  • For Q3 2024, Other Accumulated Expenses rose 15.09% year-over-year to $61000.0; the TTM value through Sep 2024 reached $61000.0, up 15.09%, while the annual FY2023 figure was $178000.0, 456.25% up from the prior year.
  • Other Accumulated Expenses for Q3 2024 was $61000.0 at RAPT Therapeutics, down from $126000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $436000.0 in Q1 2020 and bottomed at $32000.0 in Q4 2022.
  • The 5-year median for Other Accumulated Expenses is $173000.0 (2022), against an average of $179789.5.
  • The largest annual shift saw Other Accumulated Expenses crashed 90.7% in 2021 before it soared 456.25% in 2023.
  • A 5-year view of Other Accumulated Expenses shows it stood at $328000.0 in 2020, then decreased by 22.56% to $254000.0 in 2021, then crashed by 87.4% to $32000.0 in 2022, then skyrocketed by 456.25% to $178000.0 in 2023, then crashed by 65.73% to $61000.0 in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Other Accumulated Expenses are $61000.0 (Q3 2024), $126000.0 (Q2 2024), and $203000.0 (Q1 2024).